Early Bird
Stocks, crypto, and crowdfunding in 3 minutes or less.
Connect
And, Bitcoin exhibits hedge appeal.
And, Inotiv's FDA testing change.
And, Verizon Business touts new tech.
And, Bitcoin’s rough 2025, explained.
And, Tesla’s rough 2025, explained.
Plus, Bitcoin's reserve gains fade.
And, Philip Morris mulls cigar biz sale.
And, Twilio's disappointing outlook.
Plus, Apple's product overhaul.
And, Bitcoin jumps back over $100K.
Plus, Pfizer ends therapeutics deal.
And, Bitcoin's post-Christmas slump.
